Strategy, marketing, and commercial execution for healthcare technology companies.
Clearance lets you sell. Reimbursement decides whether anyone pays. What the new RAPID pathway means for your launch plan.
FDA clearance lets you sell. Reimbursement decides whether anyone pays. Learn the three questions every payer answer must resolve, and what the new RAPID pathway changes.
Read Post →
Physicians trust peers, not ads. Learn how to map real clinical influence, sustain KOL relationships, and turn credibility into adoption and revenue.
Read Post →
FDA clearance is a milestone, not a finish line. Learn why 75% of MedTech companies fail to scale after clearance and what a proven commercialization strategy actually looks like.
Read Post →We work with commercially-viable health technology companies that are ready to scale. If that sounds like you, let's talk.
Schedule a Call